GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
158.96
-2.99 (-1.85%)
At close: Dec 5, 2025, 4:00 PM EST
157.50
-1.46 (-0.92%)
After-hours: Dec 5, 2025, 7:46 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $4.59 billion as of December 5, 2025. Its market cap has increased by 135.43% in one year.
Market Cap
4.59B
Enterprise Value
4.55B
1-Year Change
135.43%
Ranking
Category
Stock Price
$158.96
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $4.59B, a decrease of -74.33%. That is a compound annual growth rate of -23.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.59B | 117.61% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |